Skip to main content
Intrasense logo

Intrasense — Investor Relations & Filings

Ticker · ALINS ISIN · FR0011179886 LEI · 969500VF6MOVQXWHAE33 PA Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 310 across all filing types
Latest filing 2021-01-13 Board/Management Inform…
Country FR France
Listing PA ALINS

About Intrasense

https://www.intrasense.fr/

Intrasense, a subsidiary of the Guerbet Group, is a medical technology company that develops and markets advanced software solutions for medical imaging. Its flagship product, the Myrian® platform, is a comprehensive visualization tool that assists healthcare professionals in reviewing and analyzing 2D and 3D medical images from modalities such as MRI and CT scanners. The company's solutions are characterized by the native integration of Artificial Intelligence (AI) algorithms to enhance diagnostic accuracy and workflow efficiency. Intrasense also offers specialized solutions, including Liflow® for oncology imaging and the DUOnco™ suite of AI tools for lesion detection. The technology aims to facilitate and secure clinical diagnosis, decision-making, and therapeutic monitoring for radiologists and other clinicians.

Recent filings

Filing Released Lang Actions
INTRASENSE:
Board/Management Information Classification · 100% confidence The document is a press release dated January 13th, 2021, announcing the appointment of Khalil Filali as the Group Chief Business Officer. This type of announcement concerns a change in senior management personnel. Based on the provided definitions, the category 'Board/Management Information' (Code: MANG) is the most appropriate classification for reporting changes in senior management.
2021-01-13 English
Intrasense : Nouveau Directeur Administratif et Financier Groupe
Board/Management Information Classification · 100% confidence The document is titled "Nouveau Directeur Administratif et Financier Groupe" (New Group Chief Financial Officer) and announces the appointment of Lionel Seltz to this position. It details his responsibilities, background, and the transition from the previous CFO. This content directly relates to changes in senior management personnel. According to the definitions, this corresponds to Board/Management Information (MANG). The document is a press release format, but the core subject matter is management change, making MANG the most specific classification over a general Regulatory Filing (RNS). The document length (3453 chars) is short, but it is the primary announcement itself, not an announcement *about* a report.
2020-11-12 French
Intrasense: New Group Chief Financial Officer
Board/Management Information Classification · 100% confidence The document is a press release dated November 12th, 2020, announcing the appointment of Lionel Seltz as the new Group Chief Financial Officer (CFO). This announcement details a change in senior management personnel. According to the definitions, 'Board/Management Information (Code: MANG)' covers the 'Announcement of changes in the company's board of directors or senior management.' The content directly aligns with this definition.
2020-11-12 English
Intrasense : Lancement de Myrian 2.8, nouvelles applications cliniques et efficacité du workflow
Regulatory Filings Classification · 100% confidence The document is titled "Communiqué de presse" (Press Release) and announces the launch of a new software version (Myrian 2.8) with new clinical applications and workflow improvements. It details product features (XP-Mammo, XP-Cardiac, XP-BrainPerfusion-CT, XP-Lung) and mentions regulatory status (CE certification, FDA approval pending/received). This type of announcement, focusing on product updates and operational news rather than mandatory financial reporting (like 10-K, ER, or IR), fits best under a general regulatory or news announcement category. Since it is a press release announcing operational news and product development, and it doesn't fit the specific definitions for financial reports, management changes, or dividend notices, it is classified as a general Regulatory Filing (RNS) or potentially an Investor Presentation (IP) if it were structured as a deck. Given the format is a press release announcing product news, RNS (Regulatory Filings/General Announcement) is the most appropriate fallback, although it shares characteristics with an Investor Presentation (IP) if the content were more strategic. However, as a formal press release announcing a product update, RNS is the standard classification for non-core financial disclosures.
2020-11-04 French
Intrasense : Myrian 2.8 launch, new clinical applications and workflow efficiency
Regulatory Filings Classification · 100% confidence The document is a press release dated November 04th, 2020, announcing the launch of a new software version (Myrian 2.8) and detailing new clinical applications and workflow efficiencies. It discusses product updates (XP-Mammo, XP-Cardiac, XP-BrainPerfusion-CT) and mentions regulatory approvals (CE certified, FDA approved) for a COVID-19 related protocol. This content is characteristic of an announcement detailing operational and product developments, rather than a formal financial filing like a 10-K, an earnings release (ER) which focuses on financial figures, or a formal regulatory filing (RNS). Since it is a press release announcing business developments and product news, it does not fit perfectly into the defined financial categories. However, given the context of corporate communications, it is closest to a general announcement. Since there is no specific category for 'Product Launch Announcement' or 'Press Release', and it is not a formal financial report, the most appropriate fallback category is 'Regulatory Filings' (RNS) as a general corporate announcement, although 'ER' or 'MDA' might be considered if the focus was financial performance. Given the strong focus on product features and clinical innovation, and the lack of financial summary, RNS is the best fit among the provided options for a non-financial, non-meeting related corporate update.
2020-11-04 English
Intrasense : Rapport Financier Semestriel
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Rapport semestriel 2020' (2020 Half-Year Report) and contains comprehensive financial data, including balance sheets, income statements, management discussion and analysis (MDA) of the business performance, and specific financial figures for the period ending June 30, 2020. It is a substantive financial report covering a period shorter than a full fiscal year, which fits the definition of an Interim/Quarterly Report (IR). H1 2020
2020-10-19 French

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.